Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
1 day ago · BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain. JOURNAVX is an ...
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
13 hours ago · BOSTON, January 30, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non ...
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
13 hours ago · The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...
Vertex: New non-opioid painkiller Journavx approved by US FDA
8 hours ago · But Journavx works in a different way, by blocking pain signals before they reach the brain. Vertex says the drug is the first in a new class of pain medicine to be approved in more than 20 years.
FDA approves Vertex non-opioid painkiller drug Journavx
13 hours ago · The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
Vertex: New non-opioid painkiller Journavx approved by US FDA
12 hours ago · But Journavx works in a different way, by blocking pain signals before they reach the brain. Vertex says the drug is the first in a new class of pain medicine to be approved in more than 20 years.
FDA approves Journavx, new non-opioid painkiller from Vertex
13 hours ago · Nonetheless, Vertex executives say Journavx’s ability to soothe pain without the risk of addiction will likely make it a blockbuster, a drug that generates sales of at least $1 billion a year.
FDA signs off on Vertex’s non-opioid pain reliever Journavx
10 hours ago · While safety is the key differentiator between Journavx and the opioids with which it will compete, another differentiator is price as Vertex will charge $15.50 for a 50mg dose of Journavx.
FDA approves Journavx, first novel painkiller in more than 20 …
12 hours ago · Journavx works by intercepting pain signals before they reach the spinal cord, rather than acting directly on the brain. Vertex said the wholesale cost would be $15.50 per 50 milligram pill, or ...
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine
12 hours ago · BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain. JOURNAVX is an effective, well ...
- Some results have been removed